back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-13 17:40 Tx date 2024-03-08 |
$XENE
Xenon Pharmaceuticals Inc. |
Garofalo, Elizabeth
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-3,500 vol |
52,975 | |
| Filed 2024-03-13 17:36 Tx date 2024-03-08 |
$XENE
Xenon Pharmaceuticals Inc. |
Garofalo, Elizabeth
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-95,583.48
-2,092 vol $45.69 each |
0 | |
| Filed 2024-03-13 17:34 Tx date 2024-03-08 |
$XENE
Xenon Pharmaceuticals Inc. |
Garofalo, Elizabeth
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-64,993.28
-1,408 vol $46.16 each |
2,092 | |
| Filed 2024-03-13 17:33 Tx date 2024-03-08 |
$XENE
Xenon Pharmaceuticals Inc. |
Garofalo, Elizabeth
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$64,959
+3,500 vol $18.56 each |
3,500 | |
| Filed 2024-03-13 17:25 Tx date 2021-06-03 |
$XENE
Xenon Pharmaceuticals Inc. |
Garofalo, Elizabeth
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-13 17:16 Tx date 2024-03-08 |
$XENE
Xenon Pharmaceuticals Inc. |
Garofalo, Elizabeth
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-3,500 vol |
||
| Filed 2023-06-05 13:35 Tx date 2023-06-02 |
$XENE
Xenon Pharmaceuticals Inc. |
Garofalo, Elizabeth
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$719,786
+18,475 vol $38.96 each |
56,475 | |
| Filed 2022-06-29 19:04 Tx date 2022-06-28 |
$XENE
Xenon Pharmaceuticals Inc. |
Garofalo, Elizabeth
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$541,980
+18,000 vol $30.11 each |
38,000 | |
| Filed 2021-06-03 21:37 Tx date 2021-06-03 |
$XENE
Xenon Pharmaceuticals Inc. |
Garofalo, Elizabeth
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
20,000 | |
| Filed 2021-06-03 21:35 Tx date 2021-06-03 |
$XENE
Xenon Pharmaceuticals Inc. |
Garofalo, Elizabeth
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|